Orexo AB (publ)'s latest marketcap:
As of 06/03/2026, Orexo AB (publ)'s market capitalization has reached $72.22 M. According to our data, Orexo AB (publ) is the 28445th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 72.22 M |
| Revenue (ttm) | 1.87 M |
| Net Income (ttm) | 54.78 M |
| Shares Out | 0 |
| EPS (ttm) | 1.57 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 07/16/2026 |
Orexo AB (publ)'s yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 06/03/2026 | $72.22 M | -3.54% | 28445 |
| 12/30/2025 | $113 M | 106.69% | 46359 |
| 12/30/2024 | $54.67 M | 3.62% | 46049 |
| 12/29/2023 | $52.76 M | -15.15% | 44400 |
| 12/30/2022 | $62.18 M | -52.51% | 42720 |
| 12/30/2021 | $130.93 M | -37.43% | 40811 |
| 12/30/2020 | $209.26 M | -10.52% | 37721 |
| 12/30/2019 | $233.86 M | 3.14% | 35158 |
| 12/28/2018 | $226.74 M | 30.42% | 33858 |
| 12/29/2017 | $173.85 M | 20.36% | 32430 |
Company Profile
About Orexo AB (publ)
Orexo AB (publ) is a specialty pharmaceutical company focused on developing and commercializing innovative pharmaceuticals and digital therapies. The company operates in the United States, European Union, and internationally.
Key Products
- Zubsolv tablets – Treatment for opioid use disorder.
- Abstral – Breakthrough pain relief for cancer patients.
- Edluar – A solution for insomnia treatment.
Pipeline Developments
- OX124 – Targeting opioid overdose.
- OX125 – Rescue medication for opioid overdose.
- OX640 – Emergency treatment for allergic reactions.
- OX-MPI – Therapy for endometriosis.
Digital Therapies
- deprexis – Digital treatment for depression.
- vorvida – Alcohol management program.
- modia – Digital support for opioid use disorder.
Collaborations
Orexo has partnered with Abera Bioscience AB to develop nasal powder vaccines using the AmorphOX technology.
Company Background
Founded in 1994, Orexo AB (publ) is headquartered in Uppsala, Sweden.
Frequently Asked Questions
-
What is Orexo AB (publ)'s (OTC-ORXOY) current market cap?As of 06/03/2026, Orexo AB (publ) (including the parent company, if applicable) has an estimated market capitalization of $72.22 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Orexo AB (publ) (OTC-ORXOY) rank globally by market cap?Orexo AB (publ) global market capitalization ranking is approximately 28445 as of 06/03/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.